心力衰竭中的C-反应蛋白:预后价值和瓦尔萨坦的作用
Inder S Anand1, Roberto Latini, Viorel G Florea
1VA Medical Center, Minneapolis, MN 55417, USA. anand001@umn.edu
Circulation
|September 1, 2005
概括
在心力衰竭患者中,C-反应蛋白 (CRP) 升高,预示着更糟糕的结果. 瓦尔萨坦可能会降低某些患者的CRP,但需要进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 心脏衰竭研究研究
背景情况:
- 在心力衰竭 (HF) 中C-反应蛋白 (CRP) 的作用尚未得到充分证实.
- 有限的研究探索了CRP在HF患者的预后价值.
研究的目的:
- 评估CRP在心力衰竭中的预后意义.
- 调查与瓦尔萨坦治疗相关的CRP变化.
主要方法:
- 从瓦尔萨坦心力衰竭试验 (Val-HeFT) 中分析的患者.
- 利用考克斯回归模型将CRP与死亡率和发病率相关联.
- 检查了在4个月和12个月的CRP变化,考虑到ACE抑制剂的使用.
主要成果:
- 在HF患者中观察到CRP水平升高 (中位数为3.23 mg/L).
- 较高的CRP四分位数与增加的死亡率和发病率风险相关.
- CRP提供了超出大脑 natriuretic的预后信息.
- 瓦尔萨坦在12个月后降低了非ACE抑制剂患者的CRP.
结论:
- 增加的CRP与严重的心力衰竭和更差的预后有关.
- CRP可以独立预测心力衰竭的死亡率和发病率.
- 需要对CRP减少及其临床影响进行进一步的研究.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
相关概念视频
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
